483 Wuxi Biologics Apr 2021

483 Wuxi Biologics Apr 2021

Jonathan Chapman FDA$119.00 - Available Now

FDA investigators audited the Wuxi Biologics - Wuxi, China facility and issued inspectional observations (via FDA 483) on 02 Apr 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Apr 2021
  • Location: Wuxi, China
  • FEI: 3010606982
Add To Cart